Coronavirus
Structural Task Force

Recent Posts

June 17, 2021
Where are the drugs?

Why are vaccines developed so quickly and treatments so slowly? In March 2020, the WHO declared COVID-19 a pandemic. Since then, 14 vaccines have entered the global market[1], and the number of immunized people grows every day. Even though vaccine development has never been this fast in history and will save many lives worldwide, people […]

Read More
June 10, 2021
Sizes of Viruses, Droplets, Aerosols, and the Construction of Masks

This article looks deep into the internal structure of masks, and discusses different types of masks and how they work. Interesting!

Read More
June 3, 2021
How SARS-CoV-2 takes over its host—NSP1, the Leader Protein

Introduction This protein is known under many different names such as non-structural protein NSP1, leader protein, host translation inhibitor and host shutoff factor. Some of these names already tell us about the function and importance of this relatively small protein. It is found in all betacoronaviruses1 and, even though it only contains 180 amino acids2, […]

Read More
May 28, 2021
Opinion: Can the Strategy of the Ongoing COVID-19 Vaccination End the Pandemic Fast Enough?

COVID-19 vaccines were developed in record time and vaccination exercise is of course ongoing in most countries. Everyone is anxious to see the pandemic come to an end for things to return to normal. As of 23rd April 2021, more than 966 million doses have been administered worldwide [1], however, we have to remember that […]

Read More
May 20, 2021
Babelian SARS-CoV-2 confusion

There is a secret code that virologists use to talk about the new coronavirus. This code is made up of synonymous words and abbreviations for each of the 28 proteins which facilitate the viral life cycle. In this article, we will shed some light on this mythical language. First of all, SARS-CoV-2 has three classes […]

Read More
April 29, 2021
Ironic: Using viruses to fight coronavirus

In addition to mRNA vaccines, another type of vaccine is employed against COVID-19: Vector vaccines—like the one from AstraZeneca—contain a mostly functioning virus. But how do they work exactly? What are their strengths and weaknesses? And finally, are they safe? The novel mRNA vaccines against SARS-CoV-2 have caused some controversy, and many concerns have been […]

Read More
April 15, 2021
Watching coronavirus multiply – the quest for structures of SARS-CoV-2 RNA polymerase

A guest entry by Hauke Hillen In order for the novel coronavirus SARS-CoV-2 to replicate, it has to achieve two basic tasks: It needs to make copies of its genome that can be packaged into new virus particles, and it needs to activate viral genes to produce the proteins that actually form new virus particles, […]

Read More
April 1, 2021
Vaccination Safety Management

Introduction: Vaccination is a great means of achieving public protection against diseases. The main goal of any vaccine manufacturer is to produce a vaccine that will be safe and effective in preventing the target disease. Before any vaccine is rolled out for mass vaccination or campaign, it must have met the required rigorous scientific and […]

Read More
March 2, 2021
SARS-CoV-2 Rapid Antigen Testing in a German Hospital

During Christmas holidays in Germany the SARS-CoV-2 infections still increased dramatically. In Miesbach, a small town near Munich and close to the Alpes, where daily winter tourism was booming during Christmas, the hospital of Agatharied exceeded the alarming value of Corona infections. In December, 50 new infections occurred among patients and staff from several different wards […]

Read More
February 22, 2021
Opinion: Press release about "Coronavirus Origin Study" by Prof. Wiesendanger and Hamburg University

“The coronavirus has led to a worldwide crisis for over a year. In a new study, nanoscientist Prof. Dr. Roland Wiesendanger illuminates the origins of the virus. His findings conclude there are a number of quality sources indicating a laboratory accident at the Wuhan Institute of Virology as the cause of the current pandemic.” This […]

Read More
Copyright © 2020 – 2021 All Rights Reserved
Coronavirus Structural Taskforce
Universität Hamburg
 powered by @ssi.st